Potential Biases in Studies of Acid-Suppressing Drugs and COVID-19 Infection.

Authors:
Etminan M; Nazemipour M; Candidate MS; Mansournia MA.

Journal:
Gastroenterology

Publication Year: 2020

DOI:
10.1053/j.gastro.2020.11.053

PMCID:
PMC7832226

PMID:
33340538

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Gastroenterology

Abbreviation: Gastroenterology

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Apposition of Fibroblasts With Metaplastic Gastric Cells Promotes Dysplastic Transition.
Lee SH; Contreras Panta EW; Gibbs D and 20 more (2023) - Transparency Score: 3/6
Elucidating the Risk of Colorectal Cancer for Variants in Hereditary Colorectal Cancer Genes.
Mahmood K; Thomas M; Qu C and 4 more (2023) - Transparency Score: 3/6
Repurposing UDCA, an FXR Inhibitor, to Prevent SARS-Cov-2 Infection.
Prayitno K; Bhat M. (2023) - Transparency Score: 2/6
RNA Sequencing Identifies Frequent Mitogen-activated Protein Kinase-associated Fusion Genes in Intr…
Lee JW; Hruban RH; Brosens LAA and 4 more (2023) - Transparency Score: 3/6
The Gut Microbial Bile Acid Modulation and Its Relevance to Digestive Health and Diseases.
Fogelson KA; Dorrestein PC; Zarrinpar A and 1 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of interest The authors have made the following disclosures: Mr Sodhi and Drs Mansournia and Nazemipour have no conflicts to report. Dr Etminan has consulted in the ranitidine and cancer litigation."

Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025